Discovery of olmesartan hexetil: A new potential prodrug of olmesartan

Authors
El-Gamal, Mohammed I.Anbar, Hanan S.Chung, Hye JinKim, Hyun-IlCho, Young-JinLee, Bong SangLee, Sun AheMoon, Ji YunLee, Dong JinKwon, DowChoi, Won-JaiJeon, Hong-RyeolOh, Chang-Hyun
Issue Date
2013-03-01
Publisher
Pergamon Press Ltd.
Citation
Bioorganic & Medicinal Chemistry Letters, v.23, no.5, pp.1347 - 1350
Abstract
Synthesis of a new ester prodrug of olmesartan, olmesartan hexetil (1), is described. It is in vitro stabilities and in vivo pharmacokinetics (PK) were evaluated. It showed high stability in simulated gastric juice, and was rapidly hydrolyzed to olmesartan in rat liver microsomes and rat plasma in vitro. C-max and AUC(last) for olmesartan were significantly increased in case of hexetil prodrug, compared with olmesartan medoxomil. Olmesartan hexetil is proposed to be an efficient prodrug of olmesartan with markedly increased oral bioavailability. (C) 2013 Elsevier Ltd. All rights reserved.
Keywords
II RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME; BIOACTIVATING HYDROLASE; MEDOXOMIL; BLOCKER; RENIN; ACIDS; II RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME; BIOACTIVATING HYDROLASE; MEDOXOMIL; BLOCKER; RENIN; ACIDS; Antihypertensive; Olmesartan medoxomil; Olmesartan hexetil; Prodrug; Ester; Pharmacokinetics
ISSN
0960-894X
URI
https://pubs.kist.re.kr/handle/201004/128254
DOI
10.1016/j.bmcl.2012.12.090
Appears in Collections:
KIST Article > 2013
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE